Arnold Ching

Arnold Ching is an Investment Analyst at ORI Capital, focusing on global biotech venture capital since January 2023. Prior to this role, Arnold served as a Buyside Equity Research Analyst at SYNCICAP and Degroof Petercam, specializing in Asia Healthcare from October 2021 to January 2023 and November 2020 to October 2021, respectively. Earlier experience includes an Investment Research Internship at Faro Capital Limited in mid-2020 and a Summer Internship at VMS Group in 2018, also in private equity with a focus on healthcare. Arnold Ching holds an MSc in Risk Management and Financial Engineering from Imperial College Business School and a BSc in Mathematics from UCL.